BUND FINANCE

BUND FINANCE › Quarterly earnings › RPRX

Earnings viewer

Royalty Pharma plc (RPRX) quarterly earnings

Healthcare · Current price US$68.67 · RPRX chart and data

Popular:NVDAAAPLMSFTGOOGLAMZNTSLAMETA

Financial metricReportedExpected (consensus)Result

Beat: ≥ +1 % above consensus (margins: ≥ +0.3 points). Miss: ≤ −1 % (margins: ≤ −0.3 points). In between: in line. “No consensus”: no published estimate; compared with the same quarter of the prior year.

Key points and management commentary

Analyst outlook and market reaction

More on RPRX

RPRX profileAnalyze entryPractice in the simulatorToday’s market analysis

Not financial advice. General information for educational purposes. Earnings, analyst consensus and prices from Financial Modeling Prep; they may be delayed or contain errors. The report timing (before the open or after the close) is inferred from the price gap. Consensus and price targets are analysts' opinions, not BUND FINANCE predictions. Past results do not guarantee future results. Legal notice